Semnur Pharmaceuticals, Inc.
SMNR- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001913577
No open-market purchases or sales by Semnur Pharmaceuticals, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $73 in total; no superinvestor holds it.
Other share classesSMNRW
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Semnur Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Semnur Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Scilex Holding Co | 10% Owner | 174,770,112Indirect | Jun 26, 2026 | 1 |
| Scilex, Inc. | 10% Owner | 174,770,112Indirect | Jun 26, 2026 | 1 |
| Xu Jiandong | 10% Owner | 510,000Indirect | Sep 16, 2024 | 0 |
| Denali Capital Global Investments LLC | 10% Owner | 510,000 | Sep 16, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2025 (view filing)7:49 PM ET | Sep 23 | 2 days | Scilex Holding Co and 1 other10% Owner | SSale | −11.9M | $16.00 | −$191.1M | −6.2%181.8M after | |
| Sep 25, 2025 (view filing)7:49 PM ET | Sep 23 | 2 days | Scilex Holding Co and 1 other10% Owner | SSale | −554.8K | $16.00 | −$8.88M | −52.6%500.0K after | |
| Sep 16, 2024 (view filing) | Aug 30 | 17 daysLate | Denali Capital Global Investments LLC10% Owner | SSaleClass B Ordinary Shares | −500.0K | – | – | –1.43M after | DerivativeDuplicate filing |
| Sep 16, 2024 (view filing) | Aug 30 | 17 daysLate | Xu Jiandong10% Owner | SSaleClass B Ordinary Shares | −500.0K | – | – | –1.43M after | Derivative |
| Apr 13, 2022 (view filing) | Apr 11 | 2 days | Denali Capital Global Investments LLC10% Owner | PPurchaseClass A Ordinary Shares | +510.0K | $10.00 | +$5.10M | New position510.0K after | Duplicate filing |
| Apr 13, 2022 (view filing) | Apr 11 | 2 days | Xu Jiandong10% Owner | PPurchaseClass A Ordinary Shares | +510.0K | $10.00 | +$5.10M | New position510.0K after |